Kaplan‒Meier analysis revealed the overall survival benefits in HCC patients with low PLEKHG5 levels, and a similar result was found in HCC patient cohort (Fig. 2J). This evidence concerns the gene PLEKHG5 and hepatocellular carcinoma.